Concepedia

Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer

Daniela A. Ferraro, Helena Garcia Schüler, Urs J. Muehlematter, Daniel Eberli, Julian Müller, Alexander Müller, Roger Gablinger, Helmut Kranzbühler, Aurelius Omlin, Philipp A. Kaufmann,

European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 61 citations · 47 references

DOI

Concepts

References

47

Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer

Anthony V. D’Amico · JAMA · 1998 · 4.5K citations

, , +14

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 3.3K citations · Full text

, , +17

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer

Philip Cornford, Joaquim Bellmunt, M. Bolla et al. · European Urology · 2016 · 1.4K citations

, , +17

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

Ali Afshar‐Oromieh, Christian M. Zechmann, A. Malcher et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 928 citations · Full text

, , +17

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

Einat Even‐Sapir, Ur Metser, Eyal Mishani et al. · PubMed · 2006 · 800 citations

, , +17